These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 22242849)
1. Falcipain inhibition as a promising antimalarial target. Marco M; Coterón JM Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849 [TBL] [Abstract][Full Text] [Related]
2. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery. Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005 [TBL] [Abstract][Full Text] [Related]
4. Falcipains and other cysteine proteases of malaria parasites. Rosenthal PJ Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657 [TBL] [Abstract][Full Text] [Related]
5. The impact of whole genome sequence data on drug discovery--a malaria case study. Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369 [TBL] [Abstract][Full Text] [Related]
6. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets. Qidwai T Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296 [TBL] [Abstract][Full Text] [Related]
13. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3. Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776 [TBL] [Abstract][Full Text] [Related]
14. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Sijwali PS; Koo J; Singh N; Rosenthal PJ Mol Biochem Parasitol; 2006 Nov; 150(1):96-106. PubMed ID: 16890302 [TBL] [Abstract][Full Text] [Related]
15. Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents. Ettari R; Previti S; Di Chio C; Zappalà M Curr Med Chem; 2021; 28(15):3010-3031. PubMed ID: 32744954 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4. Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140 [TBL] [Abstract][Full Text] [Related]
17. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity. Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777 [TBL] [Abstract][Full Text] [Related]
18. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. Moura PA; Dame JB; Fidock DA Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273 [TBL] [Abstract][Full Text] [Related]